Benitec Biopharma Inc. BNTC

Latest FY: 2025 Healthcare Biotechnology
Market Price $12.38
Market Cap $425.31M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025)
$3.29M
3-Yr CAGR: 255.7%
Net Income ↓-74.3% YoY
-$37.92M
Net Margin: -1,153.9%
Free Cash Flow ↓-20.5% YoY
-$23.61M
FCF Yield: -5.55%
EPS (Diluted) ↑80.9% YoY
$-1.05
Basic: $-1.05
Return on Equity Efficiency
-39.0%
ROA: -38.1%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (BNTC)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2019 $0.1M $-7.0M $2.6M $3.05 0.00% $4.8M $4.4M
FY 2020 $0.1M -16.4% $-2.7M $-8.3M -417.1% $-8.10 -365.6% 0.00% $-7.5M $-7.6M -274.0%
FY 2021 $0.1M -42.2% $-7.1M $-13.9M -67.8% $-3.23 +60.1% 0.00% $-12.8M $-13.1M -71.1%
FY 2022 $0.1M +23.7% $0.0M $-18.2M -31.2% $-2.23 +31.0% 0.00% $-15.9M $-15.9M -21.9%
FY 2023 $0.1M +2.7% $0.0M $-19.6M -7.4% $-14.12 -533.2% 0.00% $-18.0M $-18.0M -13.2%
FY 2024 -100.0% $-15.5M $-21.8M -11.2% $-5.51 +61.0% 0.00% $-19.4M $-19.6M -8.7%
FY 2025 $3.3M $-18.3M $-37.9M -74.3% $-1.05 +80.9% 0.00% $-23.6M $-23.6M -20.5%
$

Valuation

Market Price $12.38
Market Cap $425.31M
Enterprise Value $328.91M
P/E Ratio N/A
P/B Ratio 4.37
FCF Yield -5.55%
Dividend Yield 0.00%
Shares Outstanding 34,354,334
%

Profitability & Margins

Gross Margin -557.88%
Operating Margin -1,271.00%
Net Margin -1,153.90%
Return on Equity (ROE) -38.97%
Return on Assets (ROA) -38.07%
Asset Turnover 0.03x
Revenue 3-Yr CAGR 255.73%
🛡️

Financial Health & Liquidity

Current Ratio 54.67
Cash Ratio 54.24
Debt / Equity 0.014
Debt / Assets 0.013
Cash & Equivalents $97.74M
Total Debt $1.34M
Book Value / Share $2.83
💧

Cash Flow Efficiency

Operating Cash Flow -$23.59M
Capital Expenditures (CapEx) $18.00K
Free Cash Flow -$23.61M
OCF / Revenue -717.83%
FCF / Revenue -718.38%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-1.05
EPS (Basic) $-1.05
Dividends / Share N/A
Book Value / Share $2.83
EPS YoY Growth 80.94%
🏛️

Balance Sheet (FY 2025)

Total Assets $99.59M
Total Liabilities $2.30M
Stockholders' Equity $97.30M
Current Assets $98.52M
Current Liabilities $1.80M